Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-26

FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

FDA approves a supplemental application for testosterone cypionate from Padagis US LLC, resulting in FDA-approved labeling for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone cypionate (testosterone cypionate)

Snippet

SUPPL AP for TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)